Balance Sheet

Current Liabilities	93.3m
Accounts Payable	2.2m
Accrued Liabilities	91.1m
Non-Current Liabilities	15.3m
Other Non-Current Liabilities	15.3m

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	61	51	40	34	61	45	61	52	135	136
Cash Equivalents	61	51	40	34	61	45	61	52	135	136
Short-Term Investments	69	92	101	110	196	267	307	381	332	252
Total Receivables	4	16	20	18	29	26	30	33	34	34
Accounts Receivables	4	16	20	18	29	26	30	33	34	34
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	5	1	1	1	1	1	1	1	1	1
Other Current Assets	3	6	12	8	12	15	10	12	18	9
Total Current Assets	142	167	174	170	299	354	409	478	519	433
PP&E Net	2	5	5	5	4	15	15	12	11	9
PP&E Gross	0	5	5	5	4	15	15	12	11	9
Accumulated Depreciation	0	2	3	5	5	7	8	9	10	11
Intangible Assets	27	39	28	26	25	23	22	20	19	121
Other Long-Term Assets	1	3	3	4	4	92	88	83	85	85
Total Assets	172 N/A	213 +24%	210 -1%	205 -2%	332 +62%	484 +46%	534 +10%	594 +11%	634 +7%	648 +2%
Liabilities
Accounts Payable	1	5	5	4	5	6	6	6	5	2
Accrued Liabilities	6	46	46	39	48	54	60	69	87	85
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	0	27	0	0	0	0	0	0
Total Current Liabilities	8	51	50	70	53	60	66	74	91	88
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Other Liabilities	3	29	29	4	4	13	14	14	16	16
Total Liabilities	11 N/A	80 +634%	79 -1%	74 -6%	57 -23%	73 +28%	80 +10%	89 +11%	107 +20%	104 -3%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	288	328	346	361	336	221	197	164	158	155
Additional Paid In Capital	449	461	477	493	612	631	650	669	686	700
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	1	0
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	161 N/A	133 -17%	131 -1%	131 +0%	275 +110%	411 +49%	453 +10%	505 +11%	527 +4%	545 +3%
Total Liabilities & Equity	172 N/A	213 +24%	210 -1%	205 -2%	332 +62%	484 +46%	534 +10%	594 +11%	634 +7%	648 +2%
Shares Outstanding
Common Shares Outstanding	42	43	44	45	53	54	55	56	57	58

Vanda Pharmaceuticals Inc
NASDAQ:VNDA